Peter Lloyd Jones is a cell and molecular biologist whose initial discoveries have uncovered fundamental mechanisms in stem cell biology and human disease, including breast cancer and lung development. Jones’s work actively seeks and finds new solutions to complex problems via extreme collaborations within seemingly unrelated fields, including fashion, industrial, textile and architectural design. Jones was educated and trained at Cambridge University, UC Berkeley and U of Toronto before becoming a tenured professor of pathology and lab medicine and lecturer in architecture at The University of Pennsylvania (2005) where he also co-founded LabStudio with architect Jenny E Sabin. Currently, he is the first Associate Dean of Emergent Design and Creative Technologies at The Sidney Kimmel Medical College of Thomas Jefferson University (TJU; Est1825). In 2013, he founded MEDstudio@JEFF; a research and education space focused on RE(IN)FORM(ULAT)ING medicine.

In this lecture, Jones will discuss how the arts and humanities have played a major role in his work as a studio scientist in LabStudio and MEDstudio, and how such ventures may better prepare us all for the likely shifts in life and work brought forth by the next digital revolution.

www.labstudio.org
https://creativemornings.com/talks/peter-lloyd-jones
http://www.nightwhiteskies.com/new-blog/2016/9/25/peter-lloyd-jones

 

..........................................

 

The Convergence Sci-Art/Art-Sci Conferences series focus on the crossover of disciplines with science, especially arts and communication. The talks cover subjects like the influence of media on modern science, the public perception of the scientific method, neuroscience popular misconceptions, architecture and biology in the medical practice, or science immersed artistic practice.

 

Convergence, Perceptions of Neuroscience is an independent initiative developed in partnership with the Brain Repair and Integrative Neuroscience (BRaIN) Program of the RI-MUHC and Concordia Faculty of Fine Arts. It is supported by the Canadian Association for Neuroscience, the Research Institute of the McGill University Health Centre, McGill University, and the Montreal General Hospital Foundation.